Hotline 24/7: 0909384389

Share links:

Proximo Medical to partner with CeloNova Biosciences

Ngày 10/01/2020 09:49 | Lượt xem: 1470

Proximo Medical has announced a partnership in select US markets with CeloNova Biosciences, supplier of the COBRA PzF nanocoated coronary stent (NCS).

Carl St Bernard, chief executive officer of CeloNova Biosciences, states in the press release: “By partnering with Proximo Medical, CeloNova can leverage their tremendous expertise, experience, and scale to accelerate the overall market impact of breakthrough technologies like the COBRA PzF nanocoated coronary stent.”

Brett Martin, chief executive officer of Proximo Medical says in the statement: “We are pleased to be partnering with CeloNova, a company that is revolutionising medicine and rethinking the bounds of improved patient care.” 

Proximo Medical is a fractional commercial organisation for start-up medical device technologies and established medical device companies looking to expand adoption in the USA. CeloNova Biosciences is a global medical device company that offers products based upon its proprietary Polyzene™-F NanoCoating technology.

According to the press release, COBRA PzF NCS allows physicians to safely and effectively treat patients who may benefit from short, one-month dual antiplatelet therapy (DAPT). The statement says that in the PzF SHIELD IDE trial, COBRA PzF NCS with one-month DAPT demonstrated 0% stent thrombosis, 4.6% total lesion revascularisation at nine month follow up, and that low target lesion revascularisation (TLR) and low stent thrombosis (ST) with short DAPT is consistently demonstrated across CeloNova’s comprehensive clinical trial programme.

Source CardiovascularNews

Duc Tin Clinic

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support